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Abstract 
 
The new DO3A-derived dithiocarbamate ligand, DO3A-tBu-CS2K, is formed by treatment of the 
ammonium salt [DO3A-tBu]HBr with K2CO3 and carbon disulfide. DO3A-
tBu-CS2K reacts with 
the ruthenium complexes cis-[RuCl2(dppm)2] and [Ru(CH=CHC6H4Me-4)Cl(CO)(BTD)(PPh3)2] 
(BTD = 2,1,3-benzothiadiazole) to yield [Ru(S2C-DO3A-
tBu)(dppm)2]
+ and [Ru(CH=CHC6H4Me-
4)(S2C-DO3A-
tBu)(CO)(PPh3)2], respectively. Similarly, the group 10 metal complexes, [Pd(C,N-
C6H4CH2NMe2)Cl]2 and [PtCl2(PPh3)2] form the dithiocarbamate compounds, [Pd(C,N-
C6H4CH2NMe2)(S2C-DO3A-
tBu)] and [Pt(S2C-DO3A-
tBu)(PPh3)2]
+, under the same conditions. 
The linear gold complexes [Au(S2C-DO3A-
tBu)(PR3)] are formed by reaction of [AuCl(PR3)] (R = 
Ph, Cy) with DO3A-tBu-CS2K. However, on reaction with [AuCl(tht)] (tht = tetrahydrothiophene), 
the homoleptic digold complex [Au(S2C-DO3A-
tBu)]2 is formed. Further homoleptic examples, 
[M(S2C-DO3A-
tBu)2] (M = Ni, Cu) and [Co(S2C-DO3A-
tBu)3] are formed from treatment of 
NiCl2.6H2O, Cu(OAc)2 or Co(OAc)2, respectively, with DO3A-
tBu-CS2K. The molecular structure 
of [Ni(S2C-DO3A-
tBu)2] was determined crystallographically. The tert-butyl ester protecting 
groups of [M(S2C-DO3A-
tBu)2] (M = Ni, Cu) and [Co(S2C-DO3A-
tBu)3] are cleaved by 
trifluoroacetic acid to afford the carboxylic acid products, [M(S2C-DO3A)2] (M = Ni, Cu) and 
[Co(S2C-DO3A)3]. Complexation with Gd(III) salts yields trimetallic [M(S2C-DO3A-Gd)2] (M = 
Ni, Cu) and tetrametallic [Co(S2C-DO3A-Gd)3], with r
1 values of 11.5 (Co) and 11.0 (Cu) mM-1s-1 
per Gd center. DO3A-tBu-CS2K can also be used to prepare gold nanoparticles, Au@S2C-DO3A-
tBu, by displacement of the surface units from citrate-stabilized nanoparticles. This material can be 
transformed into the carboxylic acid derivative Au@S2C-DO3A by treatment with trifluoroacetic 
acid. Complexation with Gd(OTf)3 or GdCl3 affords Au@S2C-DO3A-Gd with an r
1 value of 4.7 
mM-1s-1 per chelate and 1500 mM-1s-1 per object. 
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Introduction 
 
Incorporating more than one metal unit into the same covalent framework leads to great 
potential benefits, especially if the properties of the different metals are complementary. Such 
multimetallic compounds are now finding application in areas as diverse as catalysis, imaging, 
therapy and sensing.1a 
While coordination polymers1b,c and metal-organic frameworks (MOFs)2 are two of the 
most high-profile settings for assemblies containing many metals, the metals being connected are 
often the same. Linking two different metal centers has traditionally proved challenging, often 
requiring protection/deprotection strategies. Alternatively, the donor combinations of the connector 
can be chosen carefully to give selectivity for certain metals over others.3a Our recent 
contributions3b-h have explored dithiocarbamate-based linkers based on the zwitterion, 
H2NC4H8NCS2, which reacts with metals selectively at the dithiocarbamate unit. Subsequent 
deprotonation of the ammonium ion with base and treatment with carbon disulfide yields a new 
dithiocarbamate, allowing addition of a second, different metal unit. In addition to successfully 
providing a simple route to heteromultimetallic complexes (2-6 metal units), this approach has also 
been used to prepare nanoparticles functionalized with ruthenium and nickel transition metal units.4 
 The clear difference in donor affinity of late transition metals (soft) and lanthanide ions 
(hard) led us to explore the possibility of using dithiocarbamates as a means of preparing 
polylanthanide systems suitable for application in Magnetic Resonance Imaging (MRI). 
MRI is a very important non-invasive medical imaging technique, however, the slow inate 
relaxation of water protons often requires the introduction of paramagnetic contrast agents to 
enhance the image quality. Among molecular contrast agents, gadolinium(III) is the dominant ion 
employed to achieve this, owing to its very slow electronic-spin relaxation rate, seven unpaired 4f 
electrons and biological stability upon chelation by high denticity ligands.5,6 The coordination of 
Gd(III) ions must provide both kinetic and thermodynamic stability in vivo to prevent 
transmetalation of the toxic ion by other endogenous metals, spontaneous dissociation and 
transligation.7,8 
Clinically used contrast agents are currently administered in high concentrations (0.1 mM) 
in order for their effects to be significant.9 As a result, development of new compounds with high 
relaxivity is important to improve the sensitivity of MRI, which in turn should lead to better image 
quality, allow the use of lower doses and thus reduce the risks of Gd(III) associated cytotoxicity. In 
addition to low toxicity, successful MRI contrast agents must possess other attributes, many of 
which depend on the number (hydration number, q) and residence lifetime (τM) of water molecules 
at the Gd(III) center. Another important factor that can have a large effect on the relaxivity is the 
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rotational correlation time (τR) of the Gd(III) complex.9 Increasing the rotational correlation time 
leads to an increased relaxation rate, therefore increasing the size of the contrast agents is an 
attractive method to improve performance.10 Having a highly symmetric contrast agent with rigid 
bonds is also advantageous because the rotational dynamics are more isotropic, which enhances the 
effect of the large molecular mass on improving relaxivity.11  
 Approaches to enhance the sensitivity of magnetic resonance contrast agents often focus on 
‘increasing the payload’, i.e. by delivering multiple Gd(III) chelates. The greater mass also 
increases r and thus increases the relaxivity of the agent by slowing rotation. Multiple Gd(III) ions 
have been incorporated into single macromolecular species such as dendrimers12 and linear 
polymers13,14 but these systems do not exhibit relaxivities as high as expected. In the linear polymer 
systems, the limited relaxivity was attributed to anisotropic rotational dynamics where the rotation 
about the short axis was fast. Dendrimeric polymer systems demonstrate higher relaxivities due to 
their more isotropic rotational dynamic.9 However, the flexible linkages between the Gd(III) 
chelates and the dendrimer core allow movement of the chelates to be partially independent from 
the whole structure, which consequently limits the relaxivity.12a To counteract this undesired effect, 
multiple Gd(III) ions have been incorporated into metal templated self-assembled complexes 
containing traditional gadolinium-binding ligands such as DOTA (1,4,7,10-tetraazacyclododecane-
1,4,7,10-tetraacetic acid) or DTPA (diethylenetriaminepentaacetic acid).15 These systems are noted 
for their compact size (with respect to dendrimeric polymers), rigidity and high number of Gd(III) 
ions. In cell imaging, having several Gd(III) ions in a small region of space can be an advantage 
over large macromolecules containing only a few Gd(III) ions, as a cell can only permit entry to a 
limited number of contrast agent molecules before they become highly cytotoxic and lead to cell 
death.16 
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Figure 1. Multimetallic complexes designed for use in MRI. 
 
The metallostar system of Tóth and coworkers (Figure 1, A) was found to be particularly 
impressive as its relaxivity of 33.2 mM-1 s-1 (60 MHz, 25 °C)16 was comparable to that of a 
PAMAM [poly(amidoamine)] dendrimer system functionalized with Gd(DOTA) units (1860 
Gd(III) ions), of much greater mass.17 In addition, the high charge on the compound was found to 
aid water solubility. However, long-term studies conducted in mouse serum showed dissociation of 
the iron-bipyridine bonds and, in phosphate-buffered saline (PBS), the inner-sphere water 
molecules were displaced by phosphate ions.18,19 Replacement of the iron(II) metal center with a 
more kinetically inert ruthenium(II) ion showed that the relaxation characteristics remained 
unchanged, however in vitro and in vivo stability studies have not yet been reported.20,21 Whilst the 
Fe(bpy)3 core of A was assumed to be essentially rigid, the local movement of the Gd(III) chelates 
was found to be five times faster than the motion of the entire molecule.18 The source of this 
flexibility within the assembly was traced to rotation about the methylene spacer between the 
Gd(III) chelates and the 2,2’-bipyridine groups. This aspect has been addressed in the 
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phenanthroline-DO3A framework (B), shown in Figure 1, by reducing rotation through chelation of 
hydroxy units attached to the phenanthroline moiety.18 
Multi-gadolinium(III) contrast agents have also been formed with the chelates linked 
without the use of d-block metals,22,23 however, these compounds fail to exhibit relaxivities 
comparable to the metallostars of Tóth et al. For example, the lower relaxivity of the recently 
reported trigadolinium DO3A compound based on a mesitylene core, Mes(DO3A-Gd)3 (Figure 1, 
C) was probably due to the anisotropic rotational character of the molecule and the flexibility 
permitted by the methylene group linkers.24 
These examples illustrate the importance of combating the independent rotational flexibility 
of the peripheral Gd(III) units as well as the additional design required to achieve this. This factor 
was significant in the choice of the dithiocarbamate unit to link the metals in the multimetallic 
systems reported in this contribution. In both dithiocarbamate complexes and the ligand itself, the 
C-N bond typically shows substantial double bond character, which is attributed to the thioureide 
resonance form. This renders the nitrogen lone pair essentially unreactive towards other species,3f,25 
and also leads to planarity of the R2NCS2M unit in complexes where bidentate coordination is 
present.25 As a result, the dithiocarbamate linkage between the transition metal center and the 
Gd(III) chelate should display minimal rotational flexibility.25 However, the downside is that the 
lack of interaction of the nitrogen with the Gd(III) center may leave this ion more susceptible to 
ligation by endogenous anions such as phosphates and bicarbonates.26 
 
Another approach to the aim of bringing many Gd(III) centers into the same assembly has 
focused on the functionalization of the surface of gold nanoparticles with paramagnetic units.27 This 
provides a complementary nanoparticle methodology to the use of superparamagnetic iron oxide 
(SPIO) nanoparticle contrast agents as Gd(III)-based agents shorten the longitudinal relaxation time 
(T1) while SPIOs shorten the transverse relaxation time (T2).
28 Recent developments in molecular 
and cellular imaging to detect disease specific molecular markers and interactions in vivo has led to 
increased interest in nanoparticles as a flexible platform.29-39 As a result of recent advances in this 
field, new nanoparticulate MRI contrast agents have been developed, which enhance their imaging 
power by incorporating extra functionalities.33 
 
The small size and large surface area of nanoparticles present many properties that can be 
utilized in MRI contrast agents. They exhibit reduced tumbling rates which, combined with their 
ability to carry high payloads of active magnetic centers, provides an enhancement of the relaxivity. 
Additionally, they have been shown to be biologically compatible and can penetrate biological 
membranes, though this is dependent on size. Larger nanoparticles can lead to prolonged 
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circulation but also lead to clearance issues in the kidneys. Conjugation to affinity ligands (e.g., 
peptides or antibodies) allows them to be targeted at cells and then penetrate the cell wall, 
depending on the groups attached. While further refinement is still needed, nanoparticulate MRI 
contrast agents offer the potential for the delivery of imaging with enhanced sensitivity and 
specificity at a low imaging agent concentration. 
 
The pioneering work of Roux et al34,35 provides useful illustrations of some of the 
challenges associated with the attachment of Gd(III) units to the surface of gold nanoparticles. 
Modification of the diethylenetriaminepentaacetic acid (DTPA) chelate used in clinical contrast 
agents to include two thiol moieties (DTDPA) was anticipated to result in secure, two-site 
anchoring of the ligand to the nanoparticle surface. However, rather than both thiol units attaching 
to the gold, it was found that only one of the sulfur tethers was attached to the gold surface with the 
ungrafted thiols forming disulfide bonds between neighboring DTDPA units. As a result, the 
Au@DTDPA nanoparticles were synthesized with a multilayered shell of DTDPA. These 
nanoparticles (containing 150 gadolinium units) showed a moderate improvement in relaxivity (r1 = 
586 mM-1 s-1) compared to the commercially available contrast agent, DTPA:Gd (r1 = 3 mM-1 s-1).21 
However, agglomeration of the nanoparticles occurred within 24 hours, hampering their use in vivo. 
This behavior was attributed to the large number of Gd(III) ions incorporated per particle, which 
overcame the electrostatic repulsion required to maintain colloidal stability. This issue was resolved 
by reducing the number of Gd(III) ions from 150 to 50 per particle.34 Subsequent strategies 
involved gold nanoparticles functionalized through a Gd-DTPA-bis(amide) conjugate of 
glutathione, however, the formation of disulfide bridges was again observed.36  
 
The attachment of surface units in addition to the imaging modality is a major advantage of 
gold nanoparticles. This is exemplified in the work of Penadés and coworkers, who showed that the 
relaxivity of contrast agents could be tuned through the choice of sugar unit used as surface co-
unit.37 Furthermore, this potential for combining functional properties in these nanomaterials make 
it possible to bring together multiple imaging modalities with the delivery of therapeutic agents.40 
For example, this approach has been employed to combine MR imaging and dark-field scattering 
microscopy to image cancer cells before selectively destroying them photothermally using NIR 
light.41 
 
While significant developments have been achieved in the design of nanoparticle-based MR 
imaging agents, a number of issues have been unearthed with the use of thiols, such as the tendency 
to form disulfide linkages rather than interacting with the gold surface.34,36 The thiol attachment 
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strategies which employ a single thiol tether29,37,38 are susceptible to the loss of the surface unit, 
especially under biological conditions, as observed commonly for many thiol-coated gold 
nanoparticles.42 Furthermore, the introduction of thiols into the gadolinium chelate can often be 
synthetically challenging and result in a significant number of extra synthetic steps. The use of a 
dithiocarbamate, which can be readily prepared from a secondary amine and carbon disulfide 
represents a straightforward approach. Additionally, it has been observed in the literature 
addressing dithiocarbamate functionalized gold nanoparticles that these surface units are 
significantly more resistant to displacement than thiols.43,44 
This contribution demonstrates how dithiocarbamate ligands based on the successful DO3A 
chelate45 could be used in the development of assemblies suitable for magnetic resonance imaging 
applications. Initially, simple monometallic systems are used in order to establish the coordination 
chemistry before the synthesis of heterotri- and tetrametallic complexes. In parallel, the use of the 
same dithiocarbamate unit is explored in the functionalization of gold nanoparticles with 
paramagnetic Gd(III) centers. 
 
 
Results and Discussion 
 
Synthesis of the dithiocarbamate-based polydentate chelate 
 
Using a literature route,46 cyclen was converted to the triester ammonium salt in good yield 
and in sufficient purity (1H NMR analysis) that further purification was not required (Scheme 1). 
Various bases (NEt3, DBU) were employed to deprotonate this compound, but potassium carbonate 
was found to work most efficiently in acetonitrile to yield the desired yellow dithiocarbamate (1) in 
91% yield. Compound 1 was found to be soluble in most solvents apart from hydrocarbons (e.g., 
hexane). The infrared spectrum displayed absorptions assigned to the ester groups at 1721 (νC=O) 
and 1151 cm-1 (νC-O), as well as νC-N and two νC-S bands attributed to the dithiocarbamate moiety at 
1453 and 990 and 969 cm-1, respectively. 1H NMR analysis of 1 revealed resonances for the CH2 
protons in three separate multiplets between 2.33 and 6.40 ppm, while two singlets were observed 
for the distinct methyl environments at 1.45 and 1.47 ppm. The 13C NMR spectrum showed 
resonances at typical chemical shift values for the substituted macrocyle, including a diagnostic 
resonance for the CS2 carbon at the characteristic low-field chemical shift of 224.4 ppm. 
Characterization of DO3A-tBu-CS2K (1) was completed using mass spectrometry and elemental 
analysis. 
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Scheme 1. Synthesis of the dithiocarbamate ligand (1). 
 
 
Monometallic complexes 
 
In order to assess the coordination chemistry of the new dithiocarbamate ligand (1), a series 
of monometallic complexes was prepared displaying octahedral, square planar and linear 
geometries. The Ru(II) complexes cis-[RuCl2(dppm)2] and [Ru(CH=CHC6H4Me-
4)Cl(BTD)(CO)(PPh3)2] (BTD = 2,1,3-benzothiadiazole) were chosen as suitable reaction partners 
for 1 as they are known to react rapidly with a wide range dithiocarbamate salts to give cationic and 
neutral species respectively.3f,4 The chloride ligands in cis-[RuCl2(dppm)2] were displaced by 1 in 
the presence of NH4PF6 to yield [Ru(S2C-DO3A-
tBu)(dppm)2]PF6 (2). Initially, the reaction was 
stirred at room temperature, however this led to incomplete reaction, probably due to difficulty in 
accommodating the steric bulk of the pendant CH2Bu
t groups. Gentle heating yielded the pale 
yellow product (2) in 84% yield (Scheme 2). Little change was observed in the solid state IR 
spectrum compared to the free ligand (1) with νC=O and νC-O absorptions observed at 1725 and 1152 
cm-1, respectively. The resonances due to the macrocycle were observed as a series of multiplets 
between 2.5 and 4.0 ppm in the 1H NMR spectrum, while the methylene protons of the dppm 
ligands appeared as a broad multiplet between 4.28 – 4.64 ppm. These resonances integrated 
correctly with those for the tertiarybutyl groups between 1.30 and 1.71 ppm. The 31P NMR 
spectrum provided information on the structural ramifications of introducing such a bulky 
dithiocarbamate ligand. The distortion of the usual octahedral geometry found in such 
dithiocarbamate complexes was evidenced by an effect on the equivalence of the phosphorus 
nuclei. The multiplet resonance observed at -5.5 ppm was assigned to the equatorial phosphorus 
nuclei while two smaller triplet resonances at -18.6 and -20.5 ppm were attributed to the axial 
phosphorus nuclei. An abundant molecular ion was observed at m/z 1459 in the mass spectrum 
(Fast Atom Bombardment, positive mode) while elemental analysis data were in good agreement 
with calculated values for the proposed formulation. 
 10 
Treatment of a deep red solution of the Ru(II) vinyl compound [Ru(CH=CHC6H4Me-
4)Cl(BTD)(CO)(PPh3)2] with one equivalent of DO3A-
tBu-CS2K in chloroform rapidly led to a 
yellow solution, indicating the loss of the BTD (2,1,3-benzothiadiazole) ligand to form 
[Ru(CH=CHC6H4Me-4)(S2C-DO3A-Bu
t)(CO)(PPh3)2] (3), as shown in Scheme 2. A singlet at 39.5 
ppm in the 31P NMR spectrum confirmed the generation of a new product and confirmed the 
phosphine ligands to adopt a mutually trans arrangement. The infrared spectroscopic data (solid 
state) associated with the dithiocarbamate ligand differed little from that found in the spectrum of 2 
apart from an intense νCO absorption at 1914 cm-1. The 1H NMR spectrum showed significant 
chemical inequivalence between the ester groups and between the NCH2 protons of the DO3A-
tBu-
CS2 ligand. The interactions between the CH2 protons closest to the dithiocarbamate led to well-
defined triplets showing a coupling of 5.8 Hz. The alkenyl -proton appeared as a doublet of 
triplets with strong coupling to Hβ (JHH = 16.8 Hz) and longer range coupling to the two equivalent 
phosphorus nuclei (JHP = 3.2 Hz). The aromatic protons of the tolyl substituent gave rise to an AB 
coupling system (JAB = 7.9 Hz) at 6.35 and 6.82 ppm, while the methyl proton was found to 
resonate at 2.23 ppm. The formation of 3 was confirmed by a molecular ion at m/z 1360 in the FAB 
mass spectrum. Good agreement was found between calculated and determined elemental analysis 
values, confirming the overall composition of the product. 
 
The focus of the reactivity studies with 1 was then moved from octahedral complexes to 
square planar systems based on group 10 metals. The reaction between [Pd(C,N-
C6H4CH2NMe2)Cl]2 and two equivalents of 1 occurred rapidly to yield a pale yellow solid in good 
yield (91%), as shown in Scheme 2. The successful formation of a new product rested largely on 
the 1H NMR spectrum, which displayed a multiplet between 3.93 – 4.03 ppm for the CH2 protons 
of the cyclometalated chelate as well as a singlet at 2.89 ppm (NMe2). The protons in α- and β-
positions to the dithiocarbamate nitrogen were rendered inequivalent, giving rise to closely-spaced 
triplets at 3.09 and 3.14 ppm and multiplets between 4.13 and 4.33 ppm, respectively. Elemental 
analysis and mass spectrometry data confirmed the formulation as [Pd(C,N-C6H4CH2NMe2)(S2C-
DO3A-But)] (4). A Pt(II) example was prepared by reaction of 1 and [PtCl2(PPh3)2] in the presence 
of excess NH4PF6. The reaction was stirred at room temperature for 16 hours (Scheme 2) to yield 
the cationic product [Pt(S2C-DO3A-Bu
t)(PPh3)2]PF6 (5). The 
31P NMR spectrum contained a 
singlet at 14.8 ppm (JPPt 3293 Hz). The 
1H NMR spectrum of the product displayed typical 
resonances for the DO3A-tBu-CS2 ligand, which integrated correctly with the aromatic resonances 
for the PPh3 ligands. The formulation was further supported by a 100% abundant molecular ion at 
m/z 1309 in the FAB mass spectrum (+ve mode). 
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 Examples of linear complexes bearing the DO3A-tBu-CS2 ligand were provided by reaction 
of [AuCl(PR3)] (R = Ph, Cy) with 1 to yield [Au(S2C-DO3A-Bu
t)(PPh3)] (6) and [Au(S2C-DO3A-
But)(PCy3)] (7), as shown in Scheme 2. In complex 6, two ν(C-S) bands at 997 and 968 cm-1 were 
observed, suggesting that the dithiocarbamate ligand was coordinated in a monodentate binding 
mode, as is typically found in Au(I) dithiocarbamate compounds. The remaining spectroscopic data 
associated with the dithiocarbamate ligand in both complexes were similar to those found for 
compounds 2 – 5. Mass spectrometry analysis of the compounds revealed molecular ions at m/z 
1049 (6) and m/z 1067 (7), confirming the overall composition of the products, in conjunction with 
elemental analysis. 
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Scheme 2. Formation of mononuclear dithiocarbamate complexes; BTD = 2,1,3-benzothiadiazole. 
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Homoleptic complexes 
 
Having probed the reactivity of the DO3A-tBu-CS2 ligand (1) with a range of metal 
complexes of differing geometries and bearing other co-ligands (allowing characterization through 
internal integration of their 1H NMR features), attention turned to the generation of homoleptic 
species. In terms of potential as contrast agents for MRI, these compounds are the most interesting 
as they allow up to three macrocycles to be incorporated into the same molecular assembly. Since 
each macrocycle can accommodate a metal ion, three Gd(III) centers can be arranged around a 
central transition metal ion. As described above, this approach has already received some attention, 
however, to date, no reports have appeared in which dithiocarbamate linkages have been explored. 
The methods used by many researchers for their transition metal centered self-assemblies 
involved initial formation of the Gd(III) chelate, followed by formation of the octahedral 
complex.15,16,18,19,47,48 The opposite approach was employed in this work, making use of the soft-
soft affinity of the transition metal core for the dithiocarbamate ligand (1), before deprotection of 
the ester groups and subsequent chelation of the Gd(III) ions. Deprotection of the tert-butyl ester 
groups is typically achieved using trifluoroacetic acid, which risked reverting the dithiocarbamate 
moiety back to its constituent amine and carbon disulfide.49 However, when dithiocarbamates are 
coordinated to a transition metal center, their stability towards acids is greatly improved.25  
 
A dinuclear Au(I) species, [Au2(S2C-DO3A-Bu
t)2] (8), was obtained by stirring equimolar 
solutions of [AuCl(tht)] (tht = tetrahydrothiophene) and dithiocarbamate 1 at room temperature 
(Scheme 3) in good yield. The solid appeared to be indefinitely air and moisture stable as a solid at 
room temperature, however, in solution the compound was susceptible to formation of gold colloid. 
The infrared spectrum showed typical absorptions for the dithiocarbamate ligand, although the νC-N 
band in 8 (1481 cm-1) was found to have increased in frequency, compared to the corresponding 
value for the dithiocarbamate ligand 1 (1453 cm-1), indicating a greater degree of C-N multiple 
bond character. The chemical shifts observed in the 1H NMR spectrum of 8 were similar to those 
found for 1 so the formulation rested largely on the FAB mass spectrum (100% abundant molecular 
ion at m/z 1573) and good agreement of elemental analysis data with calculated values. 
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Scheme 3. Formation of homoleptic bis(dithiocarbamate) complexes (tht = tetrahydrothiophene). 
 
Due its instability in solution, compound 8 proved unsuitable for the ultimate goal of 
coordination of Gd(III) ions so the focus moved to the reactions of DO3A-tBu-CS2K (1) with nickel 
and copper precursors. Nickel bis(dithiocarbamate) complexes have been known for over a 
century25,50 and the complex [Ni(S2C-DO3A-Bu
t)2] (9) formed readily on reaction of two 
equivalents of 1 with NiCl2.6H2O. The green product was obtained in 70% yield and, as with 
compound 8, the lack of significant spectroscopic change (1H NMR and IR spectroscopies) on 
coordination of the dithiocarbamate led to 13C NMR being spectroscopy to be employed. The 
diagnostic low-field resonance of the quaternary CS2 nucleus was observed to be shifted upfield to 
205.6 ppm from the position observed in the spectrum of 1. Mass spectrometry analysis (FAB, +ve 
mode) revealed an abundant molecular ion at m/z 1237, while elemental analysis further supported 
the proposed composition of the green product. Single crystals of 9 were grown by layering a 
solution of the complex in dichloromethane with methanol (Figure 2) to allow characterization of 9 
to be completed by an X-ray crystallography study. Interestingly, on closer inspection the crystals 
appeared both red and green under different light conditions, which is consistent with the previous 
observation of green/red dichroic platelets of nickel(II) bis[(aza-15-crown-5)dithiocarbamate].51 
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Figure 2. The crystal structure of the Ci-symmetric complex 9. Atoms labeled with an ‘A’ after the 
number are related to their counterparts without the letter by the center of symmetry situated at the 
nickel center. Selected bond lengths (Å) and angles (°); Ni–S(1) 2.1976(4), Ni–S(3) 2.2045(4), 
S(1)–C(2) 1.7184(16), C(2)–S(3) 1.7282(16), C(2)–N(4) 1.313(2), S(1)–Ni–S(3) 79.621(15), S(1)–
C(2)–S(3) 109.71(9). 
 
The nickel center was found to have a distorted square planar geometry with an S(1)–Ni–
S(3) chelate bite angle of angle of 79.621(15)°. The Ni–S(1) and Ni–S(3) bond lengths of 2.1976(4) 
and 2.2045(4) Å respectively, are slightly different to each other, but within the range typically 
observed for Ni(II) bis(dithiocarbamate) complexes.25 The C(2)–N(4) bond length of 1.313(2) Å 
indicates a significant degree of double bond character,52 in agreement with the high ν(C–N) 
frequency observed using infrared spectroscopy. This significant double bond character also causes 
the NiS2CNC2 moiety to be almost completely flat, the {Ni,S(1),C(2),S(3),N(4),C(5),C(15)} atoms 
being coplanar to within ca. 0.03 Å. 
 
A further example of a bis(dithiocarbamate) complex was prepared from the reaction of two 
equivalents of 1 with Cu(OAc)2. The paramagnetic product was formulated as [Cu(S2C-DO3A-
 15 
But)2] (10) on the basis of infrared, mass spectrometry and elemental analysis data. Copper 
bis(dithiocarbamate) complexes are well known and often display distorted square planar geometry. 
 
Co(III) tris(dithiocarbamate) complexes can be synthesized from Co(II) or Co(III) salts with 
three equivalents of a dithiocarbamate salt. In the former case, Co(II) bis(dithiocarbamate) 
complexes form initially before spontaneous aerial oxidation yields the Co(III) complexes. A 
particularly relevant example is the tris(dithiocarbamate) complex based on an aza-15-crown-5 
dithiocarbamate ligand.51 The compound [Co(S2C-DO3A-Bu
t)3] (11) resulted from the rapid 
reaction between one equivalent of Co(II) acetate tetrahydrate and three equivalents of 1 and was 
obtained as a dark green solid in 89% yield (Scheme 4). 1H NMR analysis revealed the expected 
resonances for the dithiocarbamate ligand with no evidence of broadening suggesting that the 
Co(III) center was low spin d6. The 1H NMR spectrum displayed triplet resonances for the ethylene 
protons closest to the dithiocarbamate nitrogen with identical JHH coupling constants of 5.3 Hz at 
4.05 and 3.10 ppm. This indicated that the compound was highly symmetrical and also that the Λ- 
and Δ-enantiomers were spectroscopically indistinguishable. A multiplet at 2.77 ppm accounted for 
24 NCH2 protons while the resonances at 3.34 and 1.47 ppm were assigned to the remaining 
methylene protons and those of the methyl groups. The 13C NMR spectrum revealed a characteristic 
low-field CS2 carbon resonance at 204.8 ppm. Mass spectrometry (FAB) displayed an abundant 
molecular ion at m/z 1828 while elemental analysis also confirmed the composition of the product. 
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Scheme 4. Formation of a homoleptic tris(dithiocarbamate) complex. 
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Deprotection and coordination of gadolinium 
 
The next phase of the investigation was to ascertain whether conversion of the ester groups 
to carboxylic acid functionality could be achieved without compromising the dithiocarbamate 
linkage (c.f. acid sensitivity of uncoordinated dithiocarbamates49). Tertiarybutyl esters are 
selectively cleaved using trifluoroacetic acid to yield the corresponding acids in a widely-used 
protocol. In each case, the [M(S2C-DO3A-Bu
t)n] (n = 2, 3) complex was dissolved in a mixture of 
dichloromethane and trifluoroacetic acid (3:1 ratio by volume) and stirred at room temperature for 
24-48 hours. This led to complete deprotection in all cases without evidence of undesired reaction 
at the 1,1-dithio chelate. 
Using this method, [Ni(S2C-DO3A-Bu
t)2] (9) was converted into [Ni(S2C-DO3A)2] (12) in 
98% yield (Scheme 5). The color of the solution remained constant throughout the reaction, 
suggesting that no significant change had taken place at the metal center or dithiocarbamate linkage 
as a result of the acidic solution. This transformation resulted in the generation of six carboxylic 
acid units, rendering complex 12 insoluble in dichloromethane and moderately soluble in alcohols 
and water. The infrared spectrum (solid state) indicated that deprotection to form the carboxylic 
acid had been successful due to the appearance of a broad νO-H absorption at 3401 cm-1. The 
remaining carboxylic acid νC=O and νC-O absorptions were still present, as were the νC-N and νC-S 
bands attributed to the dithiocarbamate ligand. 1H NMR analysis showed broad resonances with the 
correct integrals for the DO3A-CS2 ligand and an absence of methyl (Bu
t) resonances in the high 
field region. The overall formulation was supported by a molecular ion at m/z 901 in the mass 
spectrum (FAB, +ve mode) and good agreement of elemental analysis with calculated values. 
An identical procedure ensured conversion of [Cu(S2C-DO3A-Bu
t)2] (10) to [Cu(S2C-
DO3A)2] (13) in quantitative yield. Similar spectroscopic data (apart from the effect of the 
paramagnetic center) were observed as seen for the nickel analogue (12). 
 
Reaction of [Co(S2C-DO3A-Bu
t)3] (11) under the same conditions yielded [Co(S2C-
DO3A)3] (14) in 88% yield (Scheme 5). Again, the solution remained green during the reaction, 
confirming the stability of the dithiocarbamate complex 14 in acidic condition. The product only 
showed substantial solubility at room temperature in very polar solvents such as water and dimethyl 
sulfoxide. The solid state infrared spectrum displayed a new absorption at 3409 cm-1 for the νO-H 
mode. 1H NMR analysis of the product in D2O gave broad resonances that integrated correctly for 
the proposed formulation. Further analytical data confirmed the formulation of the complex.  
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Heating a mixture of a lanthanide(III) salt and the DOTA-derivative is often used to form 
the encapsulated lanthanide complexes. However, a milder route was also employed in this study 
involving stirring a solution of the compounds at room temperature for 24 hours. After precipitation 
of the products, thorough washing of the solid was employed to remove uncoordinated metal ions. 
The greater affinity of lanthanides for harder donor atoms strongly disfavored cleavage of the 
transition metal-dithiocarbamate bonds by the Gd(III) ions.53,54 
The reaction of [Ni(S2C-DO3A)2] (12) with two equivalents of gadolinium(III) chloride (or 
triflate salt) led to a color change after 24 hours (Scheme 5) and resulted in the isolation of a 
yellow-orange solid, [Ni(S2C-DO3A-Gd)2] (15). Compared to the precursor (12), the product was 
readily soluble in methanol but was still insoluble in chlorinated solvents. The unresolved features 
in the 1H NMR spectrum of 15 confirmed the paramagnetic nature of the complex. The mass 
spectrum (FAB, +ve mode) of the sample revealed a molecular ion peak at m/z 1212 which also 
displayed the correct isotopic distribution patterns. The relatively high frequency of the 
dithiocarbamate νC-N absorption at 1490 cm-1 implied a high bond order for the C-N bond due to the 
contribution of the nitrogen lone pair. This suggested that there is little or no interaction between 
the dithiocarbamate nitrogen and the Gd(III) ion, implying that the lanthanide ion was coordinated 
to only six donors of the DO3A chelate. An infrared νO-H absorption at 3358 cm-1 indicated that 
water molecules were also bound to the Gd(III) ion. The νO-C-O absorptions were observed at 1594 
and 1254 cm-1, falling in the frequency range typical for the expected ionic binding mode to 
lanthanide ions.55 
 
In a similar manner, [Cu(S2C-DO3A)2] (13) was converted into [Cu(S2C-DO3A-Gd)2] (16) 
through reaction with two equivalents of Gd(OTf)3. A better yield was obtained for this dark brown 
product compared to the analogous nickel example (15). Infrared spectroscopic data for 16 were 
found to be similar to those recorded for 15. 
 
Stirring [Co(S2C-DO3A)3] (14) with three equivalents of Gd(OTf)3 in water for 24 hours at 
room temperature led to formation of dark green [Co(S2C-DO3A-Gd)3] (17) in 65% yield. Mass 
spectrometry (FAB) revealed a molecular ion at m/z 1787. The infrared spectrum of 17 displayed a 
relatively high νC-N absorption frequency, indicating a significant degree of C-N double bond 
character. This suggested that, as with 15 and 16, there was no significant interaction between this 
nitrogen and the Gd(III) ion, providing multiple solvent coordination sites. The infrared spectrum 
of a sample of 17 (crystallized from wet methanol) supported this hypothesis through the presence 
of a νO-H absorption at 3393 cm-1 assigned to coordinated water. The coordinated water is lost on 
drying under high vacuum, as shown by the observed elemental analysis data. 
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 In order to obtain further data on this type of tetrametallic assembly, the analogous CoLa3 
complex was prepared by treating [Co(S2C-DO3A)3] (14) with three equivalents of LaCl3 to form 
the diamagnetic La(III) (f0) complex [Co(S2C-DO3A-La)3] (18) in excellent yield. The dark green 
compound displayed moderate solubility in water and was insoluble in alcohols. The 1H NMR 
spectrum of 18 showed the methylene protons of the α-carbons resonating at 4.08 ppm while the 
CH2CO2 protons gave rise to two partially overlapping singlet peaks at 3.68 ppm. The methylene 
protons of the β-carbons were observed at 3.49 ppm and the remaining NCH2 protons gave a 
multiplet centered at 3.30 ppm. The multiplicities and chemical shifts observed in 18 were almost 
identical to those found in the spectrum of the precursor (14), which indicated that the binding of 
lanthanum(III) had little effect on the chemical environment of the rest of the molecule. The 
infrared spectrum of 18 displayed a strong, broad νO-H absorption at 3303 cm-1, indicating bound 
water at the lanthanum(III) center. The remaining infrared absorptions were similar to those 
observed for 17, confirming that the two complexes were likely to be structurally similar. Elemental 
analysis data were found to be in good agreement with the proposed formulation of 18 (Scheme 5). 
 
 
Scheme 5. Deprotection of ester groups and coordination of lanthanide ions. 
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In the transformations from ester to carboxylic acid to Gd(III) chelate, infrared spectroscopy 
proved to be particularly diagnostic. For each compound: i) the formation of a broad νO-H 
absorption was observed on formation of the tricarboxylic acid; ii) a large reduction was noted in 
the frequency of the intense absorption for νC=O in the triacid to become the asymmetric νO-C-O 
absorption in the Gd(III) complex and iii) the increase in frequency of the νC-O band on going from 
triester to triacid. The dithiocarbamate νC-N and νC-S absorption bands also remained approximately 
constant throughout the entire series of compounds which implied that the bonding to the transition 
metal remained unaffected by the transformations of the macrocycles. 
 
In order to explore the properties of the gadolinium complexes, relaxivity studies were 
undertaken at 400 MHz (9.4 T). Compound 16 (Cu) gave a value of r1 = 11.0 mM
-1s-1 per Gd center 
and r1 = 22.0 mM
-1s-1 per object while 17 (Co) showed an r1 value of 11.5 mM
-1s-1 per Gd center 
and r1 = 34.5 mM
-1s-1 per object. These relaxation rates are in the typical range for complexes with 
hydration number (q) of 3, which has been shown by Mazzanti and coworkers for their dpaa ligand 
system.56a In bidentate dithiocarbamate complexes, the nitrogen lone pair is involved substantially 
in the C-N bond, such that there is significant multiple bond character. This renders the R2NCS2M 
unit coplanar, as observed in the structure of 9. This involvement is likely to preclude the 
interaction of the nitrogen lone pair with additional metal centers.25 This aspect has been exploited 
in the ring-closing metathesis of coordinated diallyldithiocarbamate ligands,3e which contrast with 
the deactivation of the catalyst in the presence of the parent diallylamine due to coordination. From 
these observations, it is assumed that the dithiocarbamate nitrogen in 16 and 17 does not coordinate 
to the gadolinium center, leading to the high q and r1 values. The slight difference in r1 values 
between 16 and 17 could be due to the increase in mass of the agent (2 vs 3 Gd centers). It must be 
noted that these compounds would bind endogenous anions, such as carbonate and phosphates, due 
to the charge and large hydration state, studies on neutral Gd(III) chelates with 2 and 3 bound 
waters, have shown high affinities for endogenous anions and are well described in literature.56 
 
 
Nanoparticle functionalization 
 
The results described above demonstrated the utility of the DO3A-CS2K (1) ligand in the 
formation of mixed transition metal–lanthanide compounds and so the same methodology was 
investigated for the surface functionalization of gold nanoparticles with 1. Recent work by 
ourselves4 and others43,57 has shown that dithiocarbamates provide a versatile alternative to the 
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ubiquitous thiols for surface functionalization of gold nanoparticles,58 offering advantages such as a 
more straightforward synthetic approach and stronger attachment to the gold surface. 
Two different methods for the preparation of gold nanoparticles were employed. The citrate 
method59 is based on the Turkevitch protocol60 and involves initial reduction of an Au(III) 
precursor with sodium citrate before addition of the sulfur surface unit to displace the citrate 
groups. The nanoparticles produced are typically 15-20 nm in diameter. The Brust-Schiffrin 
method61,62 proceeds through reduction of [AuCl4] with sodium borohydride in the presence of the 
sulfur surface unit, resulting in smaller nanoparticles between 3-5 nm in diameter. 
 
 An aqueous solution of HAuCl4 was reduced using trisodium citrate to produce a ruby red 
solution. Addition of 1 to the reaction mixture (Scheme 6) caused precipitation of a fine black 
powder, indicating the formation of dithiocarbamate-functionalized nanoparticles, [Au@S2C-
DO3A-tBu] (NP1). The nanoparticles were isolated by centrifuging before being washed repeatedly 
with water to remove unattached dithiocarbamate surface units and free citrate ions. This process 
was continued until analysis (1H NMR and infrared spectroscopy) of the washings revealed no 
signals for these species. 
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Scheme 6. Functionalisation of the surface of gold nanoparticles with DO3A-CS2 surface units. 
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1H NMR analysis of the black powder (NP1) revealed triplets at 4.42 ppm and 3.18 ppm 
which were assigned to the protons of the α-carbons. The resonances of these protons were found to 
be broadened and shifted to higher field compared to the same frequencies in the dithiocarbamate 1. 
The presence of metal colloids in liquid-phase NMR samples can create large inhomogeneities in 
the magnetic field of local chemical environments31 so these chemical shift values and broadened 
signals were taken to be indicative of successful attachment of the dithiocarbamate to the surface of 
the gold nanoparticle. Less pronounced broadening was also observed in the resonances of the 
protons of the β carbons at 3.05 ppm. A multiplet between 2.64 ppm and 2.92 ppm accounted for 
the remaining protons of the DO3A backbone, while resonances for the tertiary-butyl protons were 
observed between 1.45 and 1.47 ppm. The solid state infrared spectrum displayed similar features 
for both NP1 and the free dithiocarbamate 1, confirming the presence of the dithiocarbamate on the 
surface of the gold nanoparticles. A shift to lower frequency was observed for the vC-S absorption 
while the dithiocarbamate vC-N band remained essentially unaffected by the formation of 
nanoparticles at 1455 cm-1. No absorptions due to residual citrate ions were observed in the infrared 
spectrum. The nanoparticles produced (NP1) showed excellent stability towards the atmosphere 
and could be redispersed in organic solvents such as chloroform and acetone. Transmission 
Electron Microscopy (TEM) was used to image the nanoparticles (Figure 3) and allowed the 
average diameter to be calculated (19.7 ± 3.7 nm). Energy Dispersive X-Ray Spectroscopy (EDS) 
was also employed to analyze NP1 and revealed that sulfur was present as well as gold, while 
nitrogen, carbon and oxygen could not be differentiated with confidence. Importantly, no trace of 
potassium countercations was indicated by the EDS measurements. This is in agreement with a 
recent computational study, which suggested the anionic charge of the surface unit is balanced by 
partial positive charge on the gold atoms to which the dithiocarbamate is attached.44 
 
 The ability to control the size of the nanoparticles has significant potential in a medical 
setting, not least in the ability of the nanoparticulates to pass through certain membranes in the 
body (e.g., blood-brain barrier). In addition, the surface area will be significantly different as will 
the number of surface units. For these reasons, the Brust-Schiffrin method61 was employed to 
access nanoparticles in a smaller size range. A phase transfer agent, tetraoctylammonium bromide 
(TOAB), is typically employed in order to transfer the Au(III) ions into the organic phase. Aqueous 
HAuCl4 was treated with a chloroform solution of TOAB before the organic layer was isolated. 
Dithiocarbamate 1 was added and the sodium borohydride reducing agent was added dropwise at 
low temperature causing the reaction mixture to change from yellow to dark brown. However, the 
product showed substantial agglomeration, making it difficult to isolate. Infrared analysis indicated 
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that the phase transfer agent (TOAB) was still present and this proved difficult to remove through 
washing. In order to avoid the use of TOAB, a modification to the method62 was employed in 
which a solution of HAuCl4 in methanol was prepared, and an aqueous solution of DO3A-CS2K (1) 
added directly to the reaction mixture (Scheme 5). This created a single phase system which 
avoided the need to extract gold(III) ions into the organic layer. Addition of sodium borohydride 
led to the solution becoming brown, indicating the formation of the gold nanoparticles, Au@S2C-
DO3A-tBu (NP2). While a 3:1 gold:ligand ratio is commonly used for simple, linear thiols, a 1:1 
ratio of gold to ligand was used in this work. This follows the approach of Roux and coworkers. 
who used similar sized surface units to those employed here.34,35 The modified method showed a 
marked improvement, with the infrared spectrum displaying characteristic absorptions for the 
dithiocarbamate surface units. As observed for NP1, the infrared absorptions associated with 
dithiocarbamate 1 were maintained in NP2, while 1H NMR spectroscopic analysis further 
supported the presence of the surface units with similar resonances being observed to those 
identified for NP1. The formation of gold nanoparticles with an average particle size of 3.7 ± 1.0 
nm (Figure 3) was confirmed by TEM analysis, while EDS data also indicated the presence of 
sulfur on the surface of the nanoparticles. 
 
 
 
 
 
 
 
 
Figure 3. TEM images of NP1 (left, 19.7 ± 3.7 nm) and NP2 (right, 3.7 ± 1.0 nm). 
 
Before coordination of lanthanide ions could be attempted, conversion of the tertiarybutyl 
ester groups to the corresponding carboxylic acid was necessary. This was achieved using a similar 
procedure to that employed for the molecular complexes mentioned above using trifluoroacetic acid 
(TFA). The reaction and work-up procedures for the deprotection were based on those in the 
literature.63 Chloroform solutions of nanoparticles NP1 and NP2 were treated with excess 
trifluoroacetic acid over a 2-4 day period at room temperature (Scheme 6). The conversion was 
monitored by 1H NMR spectroscopy. The product obtained from deprotection of NP1, Au@SC2-
DO3A (NP3) was washed thoroughly with chloroform to ensure that all TFA was removed. The 
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increased solubility compared to the precursor of NP3 in more polar solvents such as methanol and 
water indicated the effect of generating six carboxylic acid groups per chelate. 
The nanoparticles prepared via the Brust-Schiffrin method (NP2) were also treated with 
TFA to afford the carboxylic acid derivative Au@S2C-DO3A (NP4). Similar solubility changes 
were observed during the successive washes with chloroform, however, the NP4 nanoparticles 
showed a less pronounced increase in solubility in polar solvents, perhaps due to the much smaller 
number of surface units on the smaller nanoparticles. 
The deprotected nanoparticles were isolated by centrifuging and dried overnight under 
vacuum. In both cases, a small amount of gold metal appeared on the inside of the centrifuging 
tube, indicating that some degradation of the nanoparticles had taken place under the harsh 
conditions of the TFA reaction. The decomposition of dithiocarbamates under acid conditions is 
known to give the free amine and carbon disulfide.49 This could result in loss of the 
dithiocarbamate from the surface of the nanoparticle. However, this process is much less favored 
for coordinated dithiocarbamate species, as observed in the successful generation of the 
multimetallic complexes 15 - 18 discussed above. Apart from the absence of the methyl resonances 
(tBu groups), only subtle differences were observed in the resonances in the 1H NMR spectra of 
nanoparticles NP3 and NP4. No resonance was observed at 11.5 ppm (corresponding to the acidic 
proton of the TFA), suggesting that excess acid had been successfully removed by washing. Taking 
the infrared spectrum of NP4 as an example, the presence of the carboxylic acid groups was 
confirmed through the observation of a broad vO-H stretch at 3368 cm
-1 along with broadened vC=O 
and vC-O absorption bands at 1721 cm
-1 and 1146 cm-1, respectively. The infrared spectrum also 
provided evidence for the presence of the dithiocarbamate linkage with absorptions at 1461 cm-1 
(vC-N) and 992, 945 (vC-S). 
The average particle size of the NP3 nanoparticles calculated from the TEM images was 
18.9 ± 4.8 nm, while the NP4 nanoparticles were found to have an average diameter of 3.7 nm ± 
0.9 nm (Figure 4). The TEM images clearly showed that the diameters of the nanoparticles were 
essentially unchanged from the triester precursors (NP1 and NP2), indicating that modification of 
the surface units does not significantly affect the mean gold core size.42  
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Figure 4. TEM images of NP3 (left, 18.9 ± 4.8 nm) and NP4 (right, 3.7 ± 0.9 nm). 
 
 The next stage of the synthesis involved complexation of Gd (III) cations to form chelated 
complexes on the surface. A methanolic solution of NP3 was stirred for 24 hours with an excess of 
Gd(OTf)3 or GdCl3 (Scheme 6). The number of surface units was estimated
64 using the diameter 
from TEM measurements and the ‘footprint’ of the DO3A-tBu-CS2 surface unit taken from the 
structure of 9 (assuming 70% coverage42) All solvent was then removed under vacuum and the 
nanoparticles were washed repeatedly with water to ensure that all uncoordinated metal ions were 
removed (determined by the xylenol orange test). Centrifuging was employed to isolate the 
nanoparticle product, Au@(S2C-DO3A-Gd) (NP5), which was then dried overnight under vacuum. 
TEM analysis revealed the average diameter of the nanoparticles to be essentially unchanged from 
the precursor NP3, with a size of 18.6 ± 4.3 nm (Fig. 5). 
 
 
 
Figure 5. TEM images of NP5 (left, 18.6 ± 4.3 nm). 
 
1H NMR analysis of the product showed significant broadening of the resonances assigned 
to water and the residual solvent peak in CD3OD, taken as first indication of the presence of 
paramagnetic Gd(III) ions in the sample. Infrared analysis supported the formation of the metalated 
macrocycle with similar changes to those observed in the generation of the molecular MGd2/3 
species (15 – 17). Evidence of both monodentate (νC=O 1717 cm-1 and νC-O 1232 cm-1) and ionic 
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binding of the Gd(III) ions was observed as well as a broad νO-H absorption at 3387 cm-1 suggesting 
the presence of coordinated water molecules. The dithiocarbamate νC-N absorption was unaffected 
by the presence of the Gd(III) ions, implying little perturbation of the dithiocarbamate bonding. The 
presence of gadolinium as well as gold and sulfur was provided by EDS analysis. The efficacy of 
NP5 as a contrast agent was assessed by relaxivity studies (at 400 MHz, 9.4 T). It was found to 
have an r1 value of 4.8 mM
-1s-1 per Gd(III) center. Based on the same approximations of the 
number of Gd(III) units per nanoparticle used above (312 Gd(III) units at 70% coverage),64 this 
corresponds to an overall r1 value of 1498 mM
-1s-1 for NP5. This value per Gd(III) center is lower 
compared with 16 and 17 and is attributed to the effects of a high magnetic field on the larger 
object. This has also been recently observed by Mazzanti and co-workers when measuring the r1 
value of nanoparticle conjugates with chelates that have 3 bound waters at high field (200 MHz).65 
Furthermore, lifetime measurements were undertaken with the Eu(III) analogue of NP5 (NP5-Eu), 
in H2O and D2O, which confirms that 3 waters bind to metal center (see Supporting information). 
 
 
Conclusion 
 
 Although both dithiocarbamate ligands and polydentate chelates have been studied 
intensively, the ligand [DO3A-tBu-CS2] (1) is the first example of a polyfunctional 
dithiocarbamate linker, which can combine both d- and f-block ions within the same assembly. We 
have demonstrated that ligand 1 can be prepared readily and in high yield, making it an excellent 
starting point for multimetallic compounds. Coordination to a wide range of metals from the 
transition series showed that 1 reacts preferentially at the dithiocarbamate unit with all the metals 
explored, leaving the heterocyclic system available for coordination to Gd(III) ions after 
deprotection. Furthermore, the functionalization of gold nanoparticles can be achieved in a 
straightforward manner using a well-established methodology to provide robust [DO3A-tBu-CS2] 
surface units. Subsequent deprotection and functionalization with Gd(III) ions leads to functioning 
relaxivity agents. For the first time, dithiocarbamates have been employed in the construction of 
assemblies, which provide a platform for the design of potential MRI contrast agents. Current 
research is concentrating on cell studies to determine stability (in view of the reduced denticity 
compared to commercial agents) and performance of these agents in a biological environment. 
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Experimental Section 
 
 General Comments. All experiments were carried out under aerobic conditions and the 
products obtained appear indefinitely stable towards the atmosphere, whether in solution or in the 
solid state. Solvents were used as received from commercial sources. The complexes [Pd(C,N-
C6H4CH2NMe2)Cl]2,
66 [AuCl(tht)],67 [PtCl2(PPh3)2],
68 [AuCl(PPh3)],
69 [AuCl(PCy3)],
70 and cis-
[RuCl2(dppm)2]
71 were prepared using literature procedures. The complex [Ru(CH=CHC6H4Me-
4)Cl(BTD)(CO)(PPh3)2] was prepared using commercially available 2,1,3-benzothiadiazole (BTD) 
in place of the 2,1,3-benzoselenadiazole (BSD) in the literature procedure.72 Petroleum ether refers 
to the fraction boiling in the range 40-60 °C. A Micromass AutoSpec Premier and Micromass LCT 
Premier instruments were used for collecting FAB and ESI mass spectrometry data respectively. 
Infrared spectroscopy was performed using a Perkin Elmer Spectrum 100 FT-IR spectrometer on 
solid samples. NMR spectroscopy data and T1 relaxation measurements were obtained at 25 °C 
using a Bruker Avance 400 spectrometer. The resonances due to the PF6 anion in the 
31P NMR 
spectra were observed in the some of the cases below but are not reported. Elemental analyses were 
provided by London Metropolitan University. TEM images and EDS data were obtained using a 
JEOL 2010 high-resolution TEM (80-200 kV) equipped with an Oxford Instruments INCA EDS 
80mm X-Max detector system. 
 
Preparation of DO3A-tBu-CS2K (1) 
A mixture of [DO3A-tBu]HBr (2.00 g, 3.358 mmol) and K2CO3 (3.71 g, 26.863 mmol) in 
acetonitrile (40 mL) was treated with carbon disulfide (0.20 mL, 3.358 mmol). The resultant yellow 
mixture was stirred for 1 h at room temperature, after which it was filtered to give a clear yellow 
solution. The solvent was removed under reduced pressure until a green-yellow foamy solid was 
present. The crude solid was dissolved in minimum chloroform and filtered through Celite to 
remove KBr and KHCO3. The solvent was removed to yield the product as a yellow solid, which 
was dried under vacuum. Yield: 1925 mg (91%). IR (solid state): 2977, 2932, 2823 (νC-H), 1721 
(νC=O), 1453 (νC-N), 1366 (δC-H), 1222, 1151 (νC-O), 1112, 990 (νC-S), 969 (νC-S), 847, 751 cm-1. 1H 
NMR (400 MHz, CDCl3): 1.45 (s, CH3, 18H), 1.47 (s, CH3, 9H), 2.33 – 3.30 (m, NCH2 + 
CH2COO
tBu, 12H + 6H), 3.92 – 4.62 (m, NCH2, 2H), 5.38 - 6.40 (m, NCH2, 2H) ppm. 13C NMR 
(101 MHz, CDCl3): 27.9 (s, CH3), 28.1 (s, CH3), 51.1 (s, NCH2), 53.4 (s, NCH2), 53.7 (s, NCH2), 
54.9 (s, NCH2), 56.9 (s, CH2COO
tBu), 57.7 (s, CH2COO
tBu), 81.4 (s, OCMe3), 81.9 (s, OCMe3), 
171.3 (s, C=O), 171.7 (s, C=O), 224.3 (s, CS2) ppm. MS (ES -ve) m/z (abundance %) = 637 (31) 
[M + 2Na]. Analysis: Calculated for C27H49KN4O6S2·0.75CHCl3: C, 46.4; H, 7.0; N, 7.8%. Found: 
C, 46.0; H, 7.1; N, 7.8%. 
 27 
 
Preparation of [Ru(S2C-DO3A-tBu)(dppm)2]PF6 (2) 
A yellow solution of 1 (50 mg, 0.080 mmol) and cis-[RuCl2(dppm)2] (75 mg, 0.080 mmol) in 
chloroform (20 mL) was treated with a solution of NH4PF6 (26 mg, 0.159 mmol) in methanol (10 
mL) and heated at 50 °C for 10 min followed by stirring at room temperature for 3.5 h. All solvent 
was removed and the resultant yellow residue was dissolved in minimum dichloromethane and 
filtered through Celite. The solution was evaporated to dryness and then triturated using ultrasound 
in diethyl ether (25 mL) to give a light yellow solid, which was filtered and dried under vacuum. 
Yield: 107 mg (84%). IR (solid state): 3056 (νC-H), 2978, 2939 (νC-H), 1725 (νC=O), 1483 (νC-N), 
1435, 1368 (δC-H), 1251, 1152 (νC-O), 1096, 1000 (νC-S), 831 (νP-F), 727, 694 cm-1. 1H NMR (400 
MHz, CD2Cl2): 1.30 – 1.71 (m, CH3, 27H), 2.37 – 4.16 (m, DO3A-tBu-CS2 ligand, 22H), 4.28 – 
4.64 (m, PCH2, 2H), 4.77 – 5.06 (m, PCH2, 2H), 6.34 – 8.33 (m, C6H5, 40H) ppm. 31P NMR (162 
MHz, CD2Cl2): - 20.5 (t, axial-P, JPP = 35.8 Hz), –18.6 (t, axial-P, JPP = 33.5 Hz), –5.8, –5.2 (m, 
equatorial-P) ppm. MS (FAB) m/z (abundance %) = 1459 (100) [M]+. Analysis: Calculated for 
C77H93F6N4P5O6RuS2·CHCl3: C, 54.3; H, 5.5; N, 3.3%. Found: C, 54.1; H, 4.9; N, 2.8%. 
 
Preparation of [Ru(CH=CHC6H4Me-4)(S2C-DO3A-But)(CO)(PPh3)2] (3) 
A solution of [Ru(CH=CHC6H4Me-4)Cl(BTD)(CO)(PPh3)2] (37 mg, 0.039 mmol) in chloroform 
(10 mL) was treated with a solution of 1 (50 mg, 0.080 mmol) in methanol (10 mL) and stirred at 
room temperature for 30 min. All solvent was evaporated and the residue was dissolved in 
minimum dichloromethane and filtered through Celite to remove KCl. All solvent was removed 
again and pentane (2 x 10 mL) was added and then evaporated to ensure as much dichloromethane 
as possible was removed. The residue was then triturated in pentane (10 mL) for 20 min until a 
light yellow precipitate had formed. This was filtered and washed with pentane (10 mL) and then 
methanol (15 mL) followed by pentane (10 mL) again to remove BTD and unreacted 2. The solid 
was then dried under vacuum. Yield: 26 mg (49 %). IR (solid state): 3056 (νC-H), 2976, 2924, 2820 
(νC-H), 1914 (νC=O), 1725 (νC=O), 1480 (νC-N), 1433, 1366 (νC-H), 1250, 1216, 1147 (νC-O), 1126, 
1091, 999 (νC-S), 984, 844, 744, 693 cm-1. 1H NMR (400 MHz, CDCl3): 1.46 – 1.48 (m, CH3, 18H), 
1.50 – 1.52 (m, CH3, 9H), 2.23 (s, p-C6H4-CH3, 3H), 2.52 (t, NCH2, 2H, JHH = 5.8 Hz), 2.58 (t, 
NCH2, 2H, JHH = 5.8 Hz), 2.60 – 2.72 (m, NCH2, 8H), 3.13 (s, CH2COOtBu, 2H), 3.15 (s, 
CH2COO
tBu, 2H), 3.23 (t, NCH2, 2H, JHH = 5.6 Hz), 3.27 (s, CH2COO
tBu, 2H), 3.54 (t, NCH2, 2H, 
JHH = 5.9 Hz), 5.48 (d, Hβ, 1H, JHH = 16.8 Hz), 6.35, 6.82 (AB, C6H4, 4H, JAB = 7.9 Hz), 7.30 – 
7.63 (m, C6H5, 30H), 7.71 (dt, Hα, 1H, JHH = 16.8, JHP = 3.2 Hz) ppm. 31P NMR (162 MHz, 
CDCl3): 39.5 (s, PPh3) ppm. MS (FAB) m/z (abundance %) = 1360 (1) [M]
+, 1098 (50) [M – 
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PPh3]
+. Analysis: Calculated for C73H88N4O7P2RuS2: C, 64.4; H, 6.5; N, 4.1%. Found: C, 64.3; H, 
6.4; N, 4.0%. 
 
Preparation of [Pd(C,N-C6H4CH2NMe2)(S2C-DO3A-But)] (4) 
A solution of [Pd(C,N-C6H4CH2NMe2)Cl]2 (22 mg, 0.040 mmol) and 1 (50 mg, 0.080 mmol) in 
chloroform (10 mL) was stirred at room temperature for 1 h. All solvent was removed under 
reduced pressure and the residue was then dissolved in minimum chloroform and filtered through 
Celite. As much solvent as possible was removed under removed pressure followed by repeated 
additions and evaporation of pentane (10 mL) until a pale yellow foamy product was produced. 
This was dried under vacuum. Yield: 60 mg (91%). IR (solid state): 3048 (νC-H), 2975, 2928, 2908, 
2834 (νC-H), 1724 (νC=O), 1503 (νC-N), 1366 (δC-H), 1147 (νC-O), 990 (νC-S), 848, 740 cm-1. 1H NMR 
(400 MHz, CD2Cl2): 1.49 (s, CH3, 27H), 2.71 – 2.83 (m, NCH2, 8H), 2.89 (s, N(CH3)2, 6H), 3.09 (t, 
CH2CH2NCS2, 2H, JHH = 5.6 Hz), 3.14 (t, S2CNCH2CH2, 2H, JHH = 5.6 Hz), 3.28 – 3.40 (m, 
CH2COO
tBu, 6H), 3.93 – 4.03 (m, C6H4CH2, 2H), 4.13 – 4.33 (m, CH2NCS2, 4H), 6.84 – 7.11 (m, 
C6H4, 4H) ppm. MS (FAB) m/z (abundance %) = 830 (12) [M]
+. Analysis: Calculated for 
C36H61N5O6PdS2: C, 52.1; H, 7.4; N, 8.4%. Found: C, 51.9; H, 7.3; N, 8.4%. 
 
Preparation of [Pt(S2C-DO3A-But)(PPh3)2]PF6 (5) 
A solution of [PtCl2(PPh3)]2 (63 mg, 0.080 mmol) and 1 (50 mg, 0.080 mmol) in chloroform (10 
mL) was treated with a solution of NH4PF6 (26 mg, 0.159 mmol) in methanol (10 mL) and stirred at 
room temperature for 16 h. All solvent was removed to give a mixture of white solids, which were 
dissolved in minimum chloroform and filtered through Celite to give a clear filtrate. The filtrate 
was concentrated to approx. 1 mL and then diethyl ether (20 mL) was added to precipitate a white 
product, which was filtered and dried under vacuum. Yield: 65 mg (56 %). IR (solid state): 3048 
(νC-H), 2975, 2928, 2908, 2834 (νC-H), 1724 (νC=O), 1503 (νC-N), 1366 (δC-H), 1147 (νC-O), 990 (νC-S), 
848, 740 cm-1. 1H NMR (400 MHz, CD2Cl2): 1.32 – 1.76 (m, CH3, 27H), 2.49 – 4.39 (m, DO3A-
tBu-CS2 ligand, 22H), 7.27 – 7.65 (m, C6H5, 30H) ppm. 31P NMR (162 MHz, CD2Cl2): 14.8 (s, 
PPh3, JPPt = 3293 Hz) ppm. MS (FAB) m/z (abundance %) = 1309 (100) [M]
+. Analysis: Calculated 
for C63H79F6N4O6P3PtS2: C, 52.0; H, 5.5; N, 3.9%. Found: C, 52.2; H, 5.4; N, 3.9%. 
 
Preparation of [Au(S2C-DO3A-But)(PPh3)] (6) 
A solution of 1 (50 mg, 0.080 mmol) and [AuCl(PPh3)] (39 mg, 0.080 mmol) in chloroform (10 
mL) was stirred at room temperature for 1 h in the dark. All solvent was removed and the resultant 
residue was dissolved in chloroform (3 mL) and filtered through Celite to give a pale yellow 
solution. All solvent was evaporated to give the product as a pale yellow foamy solid, which was 
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dried under vacuum. Yield: 35 mg (42%). IR (solid state): 3054 (νC-H), 2975, 2930, 2833 (νC-H), 
1723 (νC=O), 1479 (νC-N), 1436, 1366 (δC-H), 1249, 1218, 1147 (νC-O), 997 (νC-S), 968 (νC-S), 847, 
747, 692 cm-1. 1H NMR (400 MHz, CD2Cl2): 1.49 (s, CH3, 27H), 2.67 – 2.88 (m, NCH2, 8H), 3.17 
(t, CH2CH2NCS2, 4H, JHH = 5.8 Hz), 3.36 (s, CH2COO
tBu, 6H), 4.29 (t, CH2NCS2, 4H, JHH = 5.8 
Hz), 7.47 – 7.60 (m, o/p-C6H5, 9H), 7.60 – 7.69 (m, m-C6H5, 6H) ppm. 31P NMR (162 MHz, 
CD2Cl2): 36.1 (s, PPh3) ppm. MS (FAB) m/z (abundance %): 1049 (50) [M]
+. Analysis: Calculated 
for C45H64AuN4PO6S2: C, 51.5; H, 6.2; N, 5.3%. Found: C, 51.7; H, 6.0; N, 5.3%. 
 
Preparation of [Au(S2C-DO3A-But)(PCy3)] (7) 
A solution of 1 (50 mg, 0.080 mmol) and [AuCl(PCy3)] (41 mg, 0.080 mmol) in chloroform (10 
mL) was stirred at room temperature for 1 h in the dark. All solvent was removed and the resultant 
residue was dissolved in minimum chloroform and filtered through Celite to give a pale yellow 
solution. All solvent was evaporated to give the product as a pale yellow foamy solid, which was 
dried under vacuum. Yield: 18 mg (21%). IR (solid state): 2974, 2927, 2851 (νC-H), 1727 (νC=O), 
1477 (νC-N), 1366 (δC-H), 1249, 1217, 1148 (νC-O), 1001 (ν-S), 970 (νC-S), 850, 744 cm-1. 1H NMR 
(400 MHz, CD2Cl2): 1.25 – 1.47 (m, Cy, 14H), 1.47 – 1.52 (m, CH3, 27H), 1.61 – 2.20 (m, Cy, 
19H), 2.69 – 2.83 (m, NCH2, 8H), 3.07 – 3.22 (m, CH2CH2NCS2, 4H), 3.30 – 3.40 (m, 
CH2COO
tBu, 6H), 4.25 (t, CH2NCS2, 2H, JHH = 5.4 Hz), 4.45 (t, CH2NCS2, 2H, JHH = 5.4 Hz) 
ppm. 31P NMR (162 MHz, CD2Cl2): 55.5 (s, PCy3) ppm. MS (FAB) m/z (abundance %) = 1067 (4) 
[M]+. Analysis: Calculated for C45H82AuN4O6PS2·0.75CHCl3: C, 47.5; H, 7.2; N, 4.8%. Found: C, 
47.7; H, 7.0; N, 4.8%. 
 
Preparation of [Au2(S2C-DO3A-But)2] (8) 
A solution of 1 (50 mg, 0.080 mmol) and [AuCl(tht)] (26 mg, 0.081 mmol) in chloroform (10 mL) 
was stirred at room temperature for 1 h. All solvent was removed and the resultant residue was 
dissolved in minimum chloroform and filtered through Celite to give a yellow solution. The 
solution was concentrated and then pentane (20 mL) was added. All solvent was removed to give a 
golden yellow foamy solid, which was dried under vacuum. Yield: 37 mg (59%). IR (solid state): 
2975, 2931, 2837 (νC-H), 1724 (νC=O), 1481 (νC-N), 1365 (δC-H), 1146, 1124 (νC-O), 993 (νC-S), 847, 
744 cm-1. 1H NMR (400 MHz, CD2Cl2): 1.49 (s, CH3, 18H), 1.50 (s, CH3, 36H), 2.77 (s, NCH2, 
16H), 3.17 (t, CH2CH2NCS2, 8H, JHH = 5.4 Hz), 3.33 (s, CH2COO
tBu, 4H), 3.35 (s, CH2COO
tBu, 
8H), 4.45 (t, CH2NCS2, 8H, JHH = 5.4 Hz) ppm. MS (FAB) m/z (abundance %): 1573 (100) [M]
+. 
Analysis: Calculated for C54H98Au2N8O12S4: C, 41.2; H, 6.3; N, 7.1%. Found: C, 41.1; H, 6.2; N, 
7.0%. 
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Preparation of [Ni(S2C-DO3A-But)2] (9) 
A solution of 1 (300 mg, 0.477 mmol) and NiCl2·6H2O (57 mg, 0.239 mmol) in methanol (10 mL) 
was stirred at room temperature for 3 h, during which a green precipitate had formed. All solvent 
was removed and the residue was dissolved in a minimum volume of chloroform and filtered 
through Celite. The solution was concentrated to approx. 2 mL and methanol (20 mL) was added. 
The green solid was filtered, washed with methanol (15 mL) and hexane (10 mL) and dried under 
vacuum. Yield: 206 mg (70 %). IR (solid state): 2975, 2936, 2906 (νC-H), 1723 (νC=O), 1515 (νC-N), 
1365 (δC-H), 1214, 1216, 1145, 1129 (νC-O), 971 (νC-S), 755 cm-1. 1H NMR (400 MHz, CDCl3): 1.48 
(s, CH3, 18H), 1.49 (s, CH3, 36H), 2.76 (s, NCH2, 16H), 3.03 (t, CH2CH2NCS2, 8H, JHH = 5.2 Hz), 
3.26 – 3.36 (m, CH2COOtBu, 12H), 4.05 (t, CH2N(CS2)CH2, 8H, JHH = 5.2 Hz) ppm. 13C NMR 
(101 MHz, CDCl3): 28.2 (s, CH3), 49.2 (s, NCH2), 52.2 (s, NCH2), 53.6 (s, NCH2), 54.3 (s, 
CH2COO
tBu), 58.4 (s, NCH2), 81.1 (s, OC(CH3)3), 170.5 (s, C=O), 170.8 (s, C=O), 205.6 (s, CS2) 
ppm. MS (FAB) m/z (abundance %) = 1237 (30) [M]+. Analysis: Calculated for C54H98N8NiO12S4: 
C, 52.4; H, 8.0; N, 9.1%. Found: C, 52.5; H, 7.9; N, 8.9%. 
 
 
 
Preparation of [Cu(S2C-DO3A-But)2] (10) 
Copper(II) chloride (0.32 g, 2.380 mmol) and 1 (3.00 g, 4.770 mmol) formed a suspension in 
methanol (100 mL), the resulting dark brown reaction mixture was stirred for 3 hours at room 
temperature. All solvent was removed under reduced pressure, the brown residue was dissolved in 
the minimum amount of chloroform and passed through Celite. The filtrate was concentrated to ca. 
30 mL, pentane (80 mL) was added and the mixture triturated, after which all solvent was removed 
under reduced pressure leaving a dark brown solid that was dried under vacuum overnight. Yield: 
2.65 g (89 %). IR (solid state): 2975, 2932, 2852 (νC-H), 1720 (νC=O), 1465 (νC=N), 1424, 1366 (δC-
H), 1247, 1219 (νC-N), 1140 (νC-O), 1046, 972, 936 (νC-S), 846, 754 cm-1. 1H NMR (400 MHz, 
CDCl3): 1.48 (m, CH3, 54H), 2.89 (m, NCH2, 24H), 3.32 (m, CH2COO
tBu, 12H), 3.80 – 4.35 (m, 
CH2N(CS2)CH2, 8H) ppm. 
13C NMR (101 MHz, CDCl3): 28.4 (s, CH3), 28.6 (s,CH3), 50.9 – 54.0 
(3s, poor signal due to paramagnetism of Cu, likely to be from methylene carbons of the cyclen 
and/or tBu-ester arms), 81.0 (s, OC(CH3)3), 81.1 (s, OC(CH3)3), 207.0 (s, CS2) ppm. MS (ES +ve) 
m/z (abundance %): 1244 (1) [M]+. Elemental Analysis: Calculated for C54H100CuN8O12S4: C, 52.1; 
H, 8.1; N, 9.0 %. Found: C, 52.3; H, 7.9; N, 9.2 %.  
 
Preparation of [Co(S2C-DO3A-But)3] (11) 
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A solution of 1 (300 mg, 0.477 mmol) and Co(OAc)2·4H2O (40 mg, 0.159 mmol) in methanol (10 
mL) was stirred at room temperature for 2 h. All solvent was removed and the resultant residue was 
dissolved in minimum chloroform and filtered through Celite to give a green solution. The solution 
was concentrated to approx. 3 mL and then pentane (3 mL) was added. All solvent was then 
evaporated under reduced pressure to give a dark green foamy solid which was dried under 
vacuum. Yield: 260 mg (89 %). IR (solid state): 2976, 2933, 2839 (νC-H), 1722 (νC=O), 1487 (νC-N), 
1365 (δC-H), 1250, 1218, 1146 (νC-O), 994 (νC-S), 847, 747 cm-1. 1H NMR (400 MHz, CDCl3): 1.47 
(s, CH3, 81H), 2.67 – 2.85 (m, NCH2, 24H), 3.10 (t, CH2CH2NCS2, 12H, JHH = 5.3 Hz), 3.34 (s, 
CH2COO
tBu, 18H), 4.05 (t, CH2NCS2, 12H, JHH = 5.3 Hz) ppm. 
13C NMR (101 MHz, CDCl3): 28.3 
(s, CH3), 47.8 (s, NCH2), 51.6 (s, NCH2), 53.2 (s, CH2COO
tBu), 54.7 (s, NCH2), 57.9 (s, NCH2), 
80.9 (s, OCMe3), 170.8 (s, C=O), 170.9 (s, C=O), 204.8 (s, CS2) ppm. MS (FAB) m/z (abundance 
%) = 1828 (55) [M]+. Analysis: Calculated for C81H147CoN12O18S6: C, 53.2; H, 8.1; N, 9.2%. 
Found: C, 53.3; H, 8.0; N, 9.1%. 
 
Preparation of [Ni(S2C-DO3A)2] (12) 
A solution of 9 (206 mg, 0.166 mmol) in dichloromethane (12 mL) was treated with trifluoroacetic 
acid (4 mL) and stirred at room temperature for 50 h. All solvent was removed and the residue was 
triturated in dichloromethane (10 mL) followed by evaporation of the dichloromethane. This 
process was repeated two more times. The previous steps were repeated using methanol (3 x 10 
mL) to ensure as much trifluoroacetic acid was removed as possible. The residue was dissolved in 
methanol (5 mL) and then diethyl ether (10 mL) was added to precipitate the pale green product, 
which was washed with diethyl ether (15 mL), water (15 mL), ethanol (15 mL) and then pentane 
(15 mL) and dried under vacuum. Yield: 147 mg (98%). IR (solid state): 3401 (νO-H), 2954 (νC-H), 
2846, 2528, 1945, 1715 (νC=O), 1616, 1499 (νC-N), 1424, 1366, 1215 (νC-O), 1133, 1086, 968 (νC-S), 
880, 793, 686 cm-1. 1H NMR (400 MHz, DMSO-d6): 2.76 – 3.14 (m, NCH2, 6H), 3.42 (s(br), 
CH2COOH, 12H), 3.91 (s(br), NCH2, 26H) ppm. MS (FAB) m/z (abundance %) = 901 (1) [M]
+. 
Analysis: Calculated for C30H50N8NiO12S4: C, 40.0; H, 5.6; N, 12.4%. Found: C, 40.2; H, 5.5; N, 
12.3%. 
 
Preparation of [Cu(S2C-DO3A)2] (13) 
A dark brown dichloromethane (140 mL) solution of 10 (2.30 g, 1.847 mmol) was treated with 
trifluoroacetic acid (46 mL) and stirred at room temperature for ca. 60 hours. All solvent was then 
removed under reduced pressure and the resultant viscous green residue was triturated in 
dichloromethane (150 mL), followed by evaporation of the solvent as a means to remove any 
remaining trifluoroacetic acid. This process was repeated twice more with dichloromethane and a 
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further three times using methanol (100 mL). Finally, the resulting residue was dissolved in the 
minimum amount of methanol and excess diethyl ether (250 mL) was added to precipitate out the 
product as a brown solid that was collected by filtration. The product was washed with cold diethyl 
ether (3 x 40 mL), cold ethanol (3 x 40 mL) and cold pentane (3 x 30 mL), and then dried under 
vacuum overnight. Yield: 1.68 g (quantitative). IR (solid state): 2865 (νC-H), 1708 (νC=O), 1635 
(asym-νO-C-O), 1490 (νC=N), 1410 (δC-H), 1250 (νC-C), 1184 (νC-N), 1133 (νC-O), 1087, 985 (νC-S), 888, 
798, 685 cm-1. 1H NMR (400 MHz, D2O): 2.75 – 3.30 (m, NCH2, 24H), 3.80 (s, CH2COOH, 12H), 
3.91 (s, NCH2, 8H) ppm. MS (ES +ve) m/z (abundance %): 485 (9) [M – DO3A-CS2]+, 906 (11) 
[M]+. Elemental Analysis: Calculated for C30H52CuN8O12S4: C, 39.7; H, 5.8; N, 12.3 %. Found: C, 
39.7; H, 5.5; N, 12.41%. 
 
Preparation of [Co(S2C-DO3A)3] (14) 
A solution of 11 (100 mg, 0.055 mmol) in dichloromethane (6 mL) was treated with trifluoroacetic 
acid (2 mL) and stirred at room temperature for 45 h. All solvent was removed and the residue was 
triturated in dichloromethane (10 mL) followed by evaporation of the dichloromethane. This 
process was repeated two more times. The previous steps were repeated using methanol (3 x 10 
mL) to ensure as much trifluoroacetic acid was removed as possible. The residue was dissolved in 
methanol (2 mL) and then the green product was precipitated by careful addition of diethyl ether 
(10 mL). The green solid was filtered, washed with diethyl ether (15 mL), ethanol (15 mL) and then 
pentane (15 mL) and dried under vacuum. Yield: 64 mg (88%). IR (solid state): 3409 (νO-H), 2856 
(νC-H), 2538, 1719 (νC=O), 1621, 1485 (νC-N), 1416, 1390, 1357, 1219 (νC-O), 1189, 1132 (νC-N), 
1084, 966 (νC-S), 882, 685 cm-1. 1H NMR (400 MHz, D2O): 2.97 – 3.56 (m, NCH2, 36H), 3.67 
(s(br), CH2COOH, 18H), 4.04 (s(br), NCH2, 12H) ppm. MS (MALDI) m/z (abundance %) = 1325 
(93) [M+2H]+. Analysis: Calculated for C45H75CoN12O18S6: C, 40.8; H, 5.7; N, 12.7%. Found: C, 
40.6; H, 5.6; N, 12.6%.  
 
Preparation of [Ni(S2C-DO3A-Gd)2] (15) 
a) A suspension of 12 (30 mg, 0.033 mmol) and GdCl3 (25 mg, 0.066 mmol) in an acetate buffer 
solution (pH 5.5, 10 mL) was stirred at room temperature for 24 h. All solvent was removed and the 
solid redissolved in water (adjusted to pH 9) and filtered through Celite. The solvent was then 
removed and the turquoise crystalline product was then dried under vacuum. Yield: 20 mg (50 %). 
b) A suspension of 12 (60 mg, 0.0665 mmol) in methanol (50 mL) was treated with Gd(OTf)3 (81 
mg, 0.134 mmol) and stirred at room temperature for 24 h. All solvent was removed and the solid 
redissolved in methanol and triturated with diethyl ether (10 mL), filtered and washed further with 
diethyl ether (10 mL). The product was then dried under vacuum. Yield: 43 mg (53 %). IR (solid 
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state): 3358 (νO-H), 2950, 2885, 2265, 1731 (asym-νO-C-O), 1594 (asym-νO-C-O), 1490 (νC-N), 1414 
(sym-νO-C-O), 1254 (sym-νO-C-O), 1224, 1155 (νC-N), 1089, 1026, 980 (νC-S), 827, 719, 633 cm-1. MS 
(FAB) m/z (abundance %) = 1212 (2) [M]+. Analysis: Calculated for C30H46Gd2N8NiO12S4: C, 29.7; 
H, 3.8; N, 9.2%. Found: C, 29.4; H, 3.9; N, 9.0%.  
 
Preparation of [Cu(S2C-DO3A-Gd)2] (16) 
To a solution of 13 (1.40 g, 1.541 mmol) in water (300 mL) was added a solution of 
gadolinium(III) triflate (1.86 g, 3.077 mmol) in water (50 mL). The brown reaction mixture was 
stirred for 24 hours at room temperature. All solvent was removed under reduced pressure and the 
residue dissolved in the minimum amount of water, excess ethanol (200 mL) was added and the 
suspension was triturated. The dark brown product was collected by filtration, washed with cold 
ethanol (3 x 30 mL) and dried under vacuum overnight. Yield: 1.46 g (78 %). IR (solid state): 3325 
(νO-H), 1591 (asym-νO-C-O), 1460 (sym-νO-C-O), 1412 (δC-H), 1246, 1225 (sym-νO-C-O), 1165, 1120 
(νC-N), 1026 (νC-S), 635 cm-1. MS (ES +ve) m/z (abundance %): 1217 (1) [M]+. Analysis: Calculated 
for C30H46CuGd2N8O12S4: C, 29.6; H, 3.8; N, 9.2 %. Found: C, 30.2; H, 3.7; N, 9.2 %.  
 
 
 
Preparation of [Co(S2C-DO3A-Gd)3] (17) 
A solution of 14 (25 mg, 0.019 mmol) in water (15 mL) was treated with a solution of Gd(OTf)3 
(34 mg, 0.057 mmol) in water (3 mL) and stirred at room temperature for 24 h leading to a 
suspension. The solvent was removed under reduced pressure and the residue then dissolved in 
methanol (3 mL). Ethanol (20 mL) was added to precipitate the dark green product, which was 
washed with cold ethanol (25 mL) and diethyl ether (20 mL) and dried under vacuum. Yield: 22 mg 
(65%). IR (solid state): 3393 (νO-H), 2851 (νC-H), 1559 (asym-νO-C-O), 1488 (νC-N), 1413 (sym-νO-C-
O), 1238 (sym-νO-C-O), 1225, 1163 (νC-N), 1088, 1027 (νC-S), 726, 635 cm-1. MS (FAB) m/z 
(abundance %) = 1787 (5) [M]+. Analysis: Calculated for C45H66CoGd3N12O18S6·H2O: C, 30.3; H, 
3.7; N, 9.4%. Found: C, 30.2; H, 3.7; N, 9.4%.  
 
Preparation of [Co(S2C-DO3A-La)3] (18) 
A solution of 14 (25 mg, 0.019 mmol) in water (15 mL) was treated with LaCl3·7H2O (22 mg, 
0.058 mmol) and stirred at room temperature for 24 h. The solvent was then evaporated to give a 
green residue which was triturated in methanol (10 mL) to give a fine dark green solid. The dark 
green product was filtered and washed with methanol (20 mL) and pentane (20 mL) and dried 
under vacuum. Yield: 30 mg (92%). IR (solid state): 3303 (νO-H), 2991, 2851, 2588, 1724 (asym-νO-
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C-O), 1600 (asym-νO-C-O), 1483 (νC-N), 1405 (sym-νO-C-O), 1337, 1235 (sym-νO-C-O), 1188 (νC-N), 
1144, 1087, 1017, 967 (νC-S), 933 cm-1. 1H NMR (400 MHz, D2O): 3.16 – 3.39 (m, NCH2, 24H), 
3.49 (s(br), CH2CH2NCS2, 12H), 3.56 – 3.81 (m, CH2COO, 18H), 4.08 (s, CH2NCS2, 12H) ppm. 
MS (FAB) m/z (abundance %) not diagnostic. Analysis: Calculated for C45H66CoLa3N12O18S6: C, 
31.2; H, 3.8; N, 9.7%. Found: C, 31.0; H, 3.5; N, 9.6%. 
 
Preparation of Au@S2C-DO3A-tBu (NP1) 
A solution of HAuCl4 (198 mg, 0.58 mmol) in distilled water (600 mL) was heated at reflux with 
vigorous stirring. Trisodium citrate (602 mg, 2.33 mmol) in distilled water (50 mL) was added, and 
heating continued for 10 minutes. The reaction was stirred for a further 15 minutes at room 
temperature. A solution of 1 (1.10 g, 1.75 mmol) in distilled water (20 mL) was added dropwise 
over 10 minutes, causing precipitation of a fine solid. The reaction was allowed to stir for a further 
3 hours, and then stored overnight at 6 oC. The brown precipitate was collected by centrifuging, 
washed thoroughly with water (5 x 10 mL) and dried under vacuum. IR (solid state): 2976, 2930, 
2848 (νC-H), 1722 (νC=O), 1455 (νC-N), 1366 (δC-H), 1249, 1217, 1146 (νC-O), 969 (νC-S), 937 (νC-S), 
847, 747 cm-1. 1H NMR (400 MHz, CDCl3): 1.45, 1.46, 1.47 (s x 3, tert-Bu, 27H), 2.74 - 2.84 (m, 
NCH2, 8H), 3.10 (m, NCH2, 4H), 3.18 (t, CH2NCS2, 2H, JHH = 5.9 Hz), 3.33 - 3.40 (m, CH2CO2, 
6H), 4.42 (t, CH2NCS2, 2H, JHH = 5.9 Hz) ppm. TEM: Analysis of 100 nanoparticles gave a size of 
19.7 ± 3.7 nm. EDS: Indicated the presence of gold and sulfur. 
 
Preparation of Au@S2C-DO3A-tBu (NP2) 
A solution of HAuCl4 (270 mg, 0.79 mmol) in methanol (60 mL) was treated with a solution of 1 
(500 mg, 0.79 mmol) in water (40 mL) with vigorous stirring. The solution was cooled to 4 oC and 
stirred for 10 minutes. A freshly prepared aqueous solution (10 mL) of sodium borohydride (252 
mg, 6.66 mmol) was added dropwise over 20 minutes, with the temperature maintained at 4 oC. A 
color change from orange to dark brown was observed upon addition of the reducing agent. The 
reaction was stirred for 3 hours at 10 oC. The brown precipitate was collected by centrifuging, 
washed thoroughly with water (5 x 10 mL) and dried under vacuum. IR (solid state): 2974, 2930, 
2841 (νC-H), 1722 (νC=O), 1460 (νC-N), 1410, 1363 (δC-H), 1135 (νC-O), 993 (νC-S), 945 (νC-S), 845, 
749 cm-1. 1H NMR (400 MHz, CDCl3): 1.48, 1.49 (s x 2, tert-Bu, 27H), 2.77 - 2.84 (m, NCH2, 8H), 
2.95 (m, NCH2, 4H), 3.18 (t, CH2NCS2, 2H, JHH = 5.0 Hz), 3.35 - 3.38 (m, CH2CO2, 6H), 4.42 (t, 
CH2NCS2, 2H, JHH = 5.0 Hz) ppm. TEM: Analysis of 100 nanoparticles gave a size of 3.7 ± 1.0 
nm. EDS: Indicated the presence of gold and sulfur. 
 
Preparation of Au@S2C-DO3A (NP3) 
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Trifluoroacetic acid (0.2 mL) was added to a solution of NP1 (50 mg) in chloroform (10 mL) and 
the reaction was stirred for 60 hours. All solvents were removed and the dark brown product was 
washed with chloroform (3 x 5 mL) and cold ethanol (3 x 5 mL) to remove the acid. The product 
was dissolved in a minimum volume of methanol and precipitated with diethyl ether. Centrifuging 
was employed to collect the dark brown product and the nanoparticles were dried under vacuum. IR 
(solid state): 2432, 1739 (νC=O), 1450 (νC-N), 1410, 1364 (δC-H), 1218 (νC-O), 1101, 920 (νC-S) cm-1. 
1H NMR (400 MHz, D2O): 2.76 - 3.15 (m, NCH2, 12H), 3.23 (m, CH2NCS2, 2H), 3.34 - 3.38 (m, 
CH2CO2, 6H), 3.53 – 3.57 (m, CH2NCS2, 2H) ppm. TEM: Analysis of 100 nanoparticles gave a 
size of 18.9 ± 4.8 nm. EDS: Indicated the presence of gold and sulfur. 
 
Preparation of Au@S2C-DO3A (NP4) 
Trifluoroacetic acid (0.2 mL) was added to a solution of NP2 (50 mg) in chloroform (10 mL) and 
the reaction stirred for 72 hours. All solvent was removed and the dark brown product was washed 
with chloroform (3 x 5 mL) and cold ethanol (3 x 5 mL). The product was dissolved in a minimum 
volume of methanol and precipitated with diethyl ether. Centrifuging was employed to collect the 
dark brown product and the nanoparticles were dried under vacuum. IR (solid state): 3368 (vO-H), 
2975, 2932 (νC-H), 1721 (νC=O), 1680 (νC=O), 1461 (νC-N), 1391, 1364 (δC-H), 1231, 1197, 1146 (νC-
O), 992 (νC-S), 945 (νC-S), 833 cm-1. 1H NMR (400 MHz, CDCl3) 2.77 – 2.94 (m, NCH2, 12H), 3.11 
(m, CH2NCS2, 2H), 3.28 – 3.34 (m, CH2CO2, 6H), 4.37 (m, CH2NCS2, 2H) ppm. TEM: Analysis of 
100 nanoparticles gave a size of 3.7 ± 0.9 nm. EDS: Indicated the presence of gold and sulfur. 
 
Preparation of Au@S2C-DO3A-Gd (NP5) 
a) A suspension of NP3 (10 mg) was stirred overnight at room temperature in a 5 mM solution of 
GdCl3 (Acetate buffer, pH 5.5). After removing the supernatant aqueous solution, the nanoparticles 
were washed with water (5 x 10 mL) and then isolated by centrifuging. The black product was dried 
overnight under vacuum. b) NP3 (30 mg) was dissolved in methanol (10 mL) and treated with a 
methanolic solution (5 mL) of Gd(OSO2CF3)3 (30 mg, 0.05 mmol). The mixture was stirred for 24 
hours at room temperature. The solvent was then removed to produce a black product, which was 
dissolved in a minimum volume of methanol and precipitated with diethyl ether. The product was 
isolated by centrifuging and the nanoparticles washed with water (10 x 5 mL). The dark brown 
product was dried overnight under vacuum. IR (solid state): 3387 (νO-H), 2895 (νC-H), 1717 (νC=O), 
1605 (νC=O), 1466 (νC-N), 1362 (δC-H), 1232 (νC-O), 1145 (νC-O), 1029, 960 (νC-S), 841 cm-1. TEM: 
Analysis of 100 nanoparticles gave a size of 18.6 ± 4.3 nm. EDS: Indicated the presence of gold, 
sulfur and gadolinium. 
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Relaxation experiments 
 
Gd(III) compounds were prepared in situ by mixing the appropriate amounts of ligand and 
Gd(III) salt (99.99%; Aldrich) in H2O followed by adjustment of the pH with NaOH aqueous 
solution (pH = 7.4). The resulting solution was placed in a 1.7 mm diameter capillary which was 
sealed. The absence of free gadolinium was determined in all samples by the xylenol orange test. 
The 1/T1 measurements were performed on a Bruker Avance DRX400 spectrometer (400MHz). 
Gadolinium content in the range of 312 complexes per Gold Nanoparticle was determined for 
independent syntheses by combined magnetic susceptibility measurements and TEM 
measurements.64 
 
 
 
 
 
 
Crystallography 
 
Table 1 provides a summary of the crystallographic data for compound 9. Data were 
collected using an Oxford Diffraction Xcalibur 3 diffractometer, and the structure was refined 
based on F2 using the SHELXTL and SHELX-97 program systems.74 CCDC 930886. 
 
Table 1. Crystallographic Data for compound 9. 
 
data 9 
chemical 
formula 
C54H98N8NiO12
S4 s lvent —
fw 1238.35 
T (°C) –100 
space group P-1 (no. 2) 
a (Å) 11.2673(5) 
b (Å) 12.2807(5) 
c (Å) 13.3887(4) 
α (deg) 111.889(3) 
β (deg) 94.522(3) 
γ (deg) 104.051(3) 
V (Å3) 1637.83(12) 
Z 1 [a] 
ρcalcd (g cm–3) 1.256 
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λ (Å) 0.71073 
μ (mm–1) 0.484 
R1(obs) [b] 0.0465 
wR2(all) [c] 0.1323 
 
 
[a] The molecule has crystallographic Ci symmetry. [b] R1 = Σ||Fo| – |Fc||/Σ|Fo|. [c] wR2 = {Σ[w(Fo2 – Fc2)2] / Σ[w(Fo2)2]}1/2; w–1 = 
σ2(Fo2) + (aP)2 + bP. 
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 A polydentate macrocyclic ligand bearing a dithiocarbamate unit has been employed in the 
construction of multimetallic assemblies containing both lanthanides and transition metal ions. 
Gold nanoparticles of varying sizes have been prepared and a representative example functionalized 
with gadolinium ions using the same ligand. Relaxivity data have been collected on both types of 
materials. 
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